Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1527)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$537.40
Total Value
$214.42K
Shares Held After
49,614
% of Holdings
0.8%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
5,000
Price
$1.77
Total Value
$8.85K
Shares Held After
10,100
% of Holdings
49.5%
Tonix Pharmaceuticals Holding Corp. (TNXP)
Taylor Carolyn E. — Director
Shares
1,415
Price
$10.55
Total Value
$14.93K
Shares Held After
1,833
% of Holdings
77.2%
ARS Pharmaceuticals, Inc. (SPRY)
Karas Eric — Chief Commercial Officer
Shares
25,000
Price
$10.00
Total Value
$250.00K
Shares Held After
12,176
% of Holdings
67.2%
ARS Pharmaceuticals, Inc. (SPRY)
Fitzpatrick Alexander A — Chief Legal Officer
Shares
3,355
Price
$10.00
Total Value
$33.55K
Shares Held After
90,910
% of Holdings
3.6%
Alkermes plc. (ALKS)
Wright Christopher I — Director
Shares
2,000
Price
$45.10
Total Value
$90.20K
Shares Held After
25,680
% of Holdings
7.2%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
12,583
Price
$70.11
Total Value
$882.18K
Shares Held After
38,743
% of Holdings
24.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,349
Price
$23.93
Total Value
$151.90K
Shares Held After
63,443
% of Holdings
9.1%
Syndax Pharmaceuticals Inc (SNDX)
Botwood Nicholas A.J. — Head of R&D, CMO
Shares
31,235
Price
$18.14
Total Value
$566.60K
Shares Held After
60,885
% of Holdings
33.9%
Summit Therapeutics Inc. (SMMT)
Zanganeh Mahkam — Director
Shares
3,810,000
Price
$13.12
Total Value
$49.99M
Shares Held After
573,883,879
% of Holdings
0.7%
Summit Therapeutics Inc. (SMMT)
DUGGAN ROBERT W — Director
Shares
3,810,000
Price
$13.12
Total Value
$49.99M
Shares Held After
573,883,879
% of Holdings
0.7%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
1,462
Price
$4.12
Total Value
$6.02K
Shares Held After
149,377
% of Holdings
1.0%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
15
Price
$0.01
Total Value
$0.15
Shares Held After
49
% of Holdings
23.4%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
3
Price
$0.01
Total Value
$0.03
Shares Held After
64
% of Holdings
4.7%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
1
Price
$0.01
Total Value
$0.01
Shares Held After
61
% of Holdings
1.6%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
1
Price
$0.01
Total Value
$0.01
Shares Held After
60
% of Holdings
1.7%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
1
Price
$0.02
Total Value
$0.02
Shares Held After
59
% of Holdings
1.7%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
1
Price
$0.02
Total Value
$0.02
Shares Held After
58
% of Holdings
1.7%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
5,000
Price
$19.00
Total Value
$95.00K
Shares Held After
411,775
% of Holdings
1.2%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
756
Price
$261.00
Total Value
$197.32K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
428
Price
$257.63
Total Value
$110.27K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
149
Price
$258.81
Total Value
$38.56K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
200
Price
$258.28
Total Value
$51.66K
Shares Held After
149
% of Holdings
57.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
859
Price
$257.59
Total Value
$221.27K
Shares Held After
349
% of Holdings
71.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
741
Price
$256.23
Total Value
$189.87K
Shares Held After
1,208
% of Holdings
38.0%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
626
Price
$261.20
Total Value
$163.51K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
120
Price
$257.53
Total Value
$30.90K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
49
Price
$256.39
Total Value
$12.56K
Shares Held After
120
% of Holdings
29.0%
BeOne Medicines Ltd. (ONC)
Rosenberg Aaron — Chief Financial Officer
Shares
631
Price
$257.74
Total Value
$162.64K
Shares Held After
0
% of Holdings
100.0%
Corvus Pharmaceuticals, Inc. (CRVS)
Moore David Scott — Director
Shares
21,700
Price
$11.53
Total Value
$250.24K
Shares Held After
21,700
% of Holdings
100.0%
Pelthos Therapeutics Inc. (PTHS)
Davis Todd C — Director
Shares
503
Price
$28.73
Total Value
$14.45K
Shares Held After
75,834
% of Holdings
0.7%
Pelthos Therapeutics Inc. (PTHS)
Davis Todd C — Director
Shares
35,445
Price
$27.80
Total Value
$985.53K
Shares Held After
75,331
% of Holdings
47.1%
Keros Therapeutics, Inc. (KROS)
Newton Charles W. — Director
Shares
550
Price
$10.04
Total Value
$5.52K
Shares Held After
12,665
% of Holdings
4.2%
CervoMed Inc. (CRVO)
BOGER JOSHUA S — Director
Shares
955,414
Price
$3.14
Total Value
$3.00M
Shares Held After
1,795,865
% of Holdings
53.2%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
19,131
Price
$70.28
Total Value
$1.34M
Shares Held After
121,863
% of Holdings
13.6%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
5,749
Price
$70.28
Total Value
$404.03K
Shares Held After
140,994
% of Holdings
3.9%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
200
Price
$150.17
Total Value
$30.03K
Shares Held After
158,222
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
4,600
Price
$149.64
Total Value
$688.36K
Shares Held After
158,422
% of Holdings
2.8%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
1,800
Price
$148.72
Total Value
$267.70K
Shares Held After
163,022
% of Holdings
1.1%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
500
Price
$147.27
Total Value
$73.64K
Shares Held After
164,822
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
700
Price
$146.04
Total Value
$102.23K
Shares Held After
165,322
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
885
Price
$145.15
Total Value
$128.46K
Shares Held After
166,022
% of Holdings
0.5%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
1,315
Price
$144.28
Total Value
$189.73K
Shares Held After
166,907
% of Holdings
0.8%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
2,800
Price
$6.17
Total Value
$17.28K
Shares Held After
700,000
% of Holdings
0.4%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
5,100
Price
$1.75
Total Value
$8.90K
Shares Held After
5,100
% of Holdings
100.0%
uniQure N.V. (QURE)
Meek David D. — Director
Shares
1,993
Price
$27.06
Total Value
$53.93K
Shares Held After
39,747
% of Holdings
4.8%
uniQure N.V. (QURE)
O'Keefe Kylie — Chief Customer & Strat Officer
Shares
15,936
Price
$27.06
Total Value
$431.23K
Shares Held After
108,864
% of Holdings
12.8%
uniQure N.V. (QURE)
Gut Robert — Director
Shares
2,726
Price
$27.06
Total Value
$73.77K
Shares Held After
32,259
% of Holdings
7.8%
uniQure N.V. (QURE)
Springhorn Jeremy P. — Director
Shares
1,993
Price
$27.06
Total Value
$53.93K
Shares Held After
43,251
% of Holdings
4.4%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
22,417
Price
$70.13
Total Value
$1.57M
Shares Held After
51,326
% of Holdings
30.4%
Showing 501–550 of 1527 transactions (page 11 of 31)